Mankind Pharma

In a regulatory filing, the company said the transaction was completed on August 31, 2026

Partnership with Chongqing Chenan Biopharmaceutical covers Insulin Degludec and Insulin Degludec + Aspart Combination

Mankind Pharma has announced a strategic collaboration with Denovo Sciences to launch an AI-led drug discovery programme, marking…

Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…

Actimed Therapeutics, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment…

Mankind Pharma, India’s fourth largest pharmaceutical company, announced a collaboration with OpenAI, a leading AI research and…

Mankind Pharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical…

The final panel discussion on Day 2 of the FDD Conclave 2025 focused on how formulation science can evolve to better serve special…

Drug delivery is undergoing a transformation driven by the demand for patient-friendly, painfree alternatives. As pharma R&D…

As pharma supply chains rise in strategic importance, its leaders must sharpen their business acumen and competencies to keep pace…